G. Schernthaner

First name

G.

Last name

Schernthaner

Bannister, C. A., Holden, S. E., Jenkins-Jones, S., Morgan, C. L., Halcox, J. P., Schernthaner, G., et al. (2014). Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes Obes Metab. http://doi.org/10.1111/dom.12354

View

Holden, S. E., Jenkins-Jones, S., Morgan, C. L., Schernthaner, G., & Currie, C. J. (2015). Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer. Diabetes Obes Metab. http://doi.org/10.1111/dom.12412

View

Holden, S. E., Jenkins-Jones, S., Morgan, C. L., Peters, J. R., Schernthaner, G., & Currie, C. J. (2017). Prevalence, glucose control and relative survival of people with Type 2 diabetes in the UK from 1991 to 2013. Diabet Med. http://doi.org/10.1111/dme.13332

View